Purchase Order W81K0221P0018
Award Date
10/1/20
Potential Completion Date
9/30/25
Potential Value
$1.9M
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Awardee
Biofire Diagnostics LLC
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Emigration Canyon, UT 84108, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm-fixed-price purchase order contract was awarded by the Defense Health Agency to Biofire Diagnostics LLC, a foreign-owned, for-profit biotechnology company based in Salt Lake City, Utah. The $3,574,052.08 contract is for a molecular assay analyzer, associated reagents, maintenance, and consumables to support testing for respiratory, blood culture, gastrointestinal, and meningitis/encephalitis targets, including COVID-19, at the Naval Medical Center in Portsmouth, Virginia. The...
This is a firm fixed-price purchase order awarded by the Air Combat Command (ACC) to Biofire Diagnostics LLC, a foreign-owned, for-profit biotechnology company based in Salt Lake City, Utah. The $434,982.96 contract is for the provision of Biofire's FilmArray diagnostic systems, COVID-19 testing reagents, infectious disease testing panels, equipment maintenance services, and cost-per-test diagnostic solutions. The contract does not have a set-aside designation, indicating open competition....
This is a $2,474,747.75 fixed-price purchase order awarded by the Defense Health Agency to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, for the provision of testing kits and panels for Bloodstream Infections, COVID-19, Meningitis/Encephalitis, and other infectious diseases. The contract has an ultimate completion date of April 29, 2026 and does not utilize a set-aside designation. Biofire Diagnostics LLC is an experienced federal contractor, holding several indefinite...
This is a $1,538,009.04 firm fixed-price purchase order contract awarded by the Defense Health Agency to Biofire Defense LLC, a for-profit limited liability company based in Utah. The contract is for the delivery of a Molecular Assay Analyzer and does not have a set-aside designation. Biofire Defense is a manufacturer of specialized biological agent identification products and advanced diagnostic solutions. The company has a strong focus on biological threat detection, infectious disease...
This is a federal contract award from the Department of the Army Medical Command to Biofire Diagnostics LLC, a for-profit, foreign-owned biotech company, for the delivery of Respiratory Panel Kits. The contract has a firm fixed price of $665,402.10 and a completion date of September 30, 2020. No set-aside designation was used. Biofire Diagnostics LLC is a leader in syndromic infectious disease testing and has received numerous federal contract awards as a prime contractor to provide a variety of...
The Defense Health Agency (DOD) awarded a $746,778 firm fixed price purchase order contract to Biofire Defense LLC of Salt Lake City, Utah. The contract is for the delivery of 184 kits containing 30 tests each of Biofire Defense's RESPIRATORY PANEL 2.1 in vitro diagnostic test panels. The place of performance is Biofire Defense's facility in Salt Lake City and the period of performance runs from June 16, 2022 through September 14, 2022. The contract was awarded under the National Interest Action...
This is a delivery order awarded by the Department of the Navy Bureau of Medicine and Surgery to Biofire Diagnostics LLC, a foreign-owned for-profit biotechnology company, to provide respiratory and gastrointestinal diagnostic test kits. The award is $199,800.15 and is a firm fixed-price delivery order against Biofire's General Services Administration Federal Supply Schedule contract for in vitro diagnostics, reagents, and tests. The place of performance is Emigration Canyon, Utah. No...
The Defense Health Agency (DOD) awarded a $742,431.36 firm fixed price purchase order to Biofire Defense LLC of Salt Lake City, Utah. The contract is to provide Respiratory Panel 2.1 In Vitro Diagnostic tests from November 7, 2022 through January 11, 2023. Biofire Defense LLC will deliver their Biofire Respiratory Panel 2.1 tests, which can rapidly detect more than twenty common respiratory pathogens including influenza A and B, respiratory syncytial virus, rhinovirus/enterovirus, coronavirus...
This is a $44,100 firm fixed-price purchase order awarded by the Defense Health Agency to Biofire Diagnostics LLC, a foreign-owned, for-profit biotechnology company, for the maintenance of Biofire FilmArray 2.0 diagnostic systems during fiscal year 2023. The contract has a completion date of June 14, 2028 and does not utilize a set-aside designation, indicating open competition. Biofire Diagnostics specializes in syndromic infectious disease testing and has been awarded numerous federal...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit organization, for the provision of BIOFIRE RP2.1 RESPIRATORY PANEL COVID-19 TESTING. The contract, which does not have a set-aside designation, has a potential value of $115,425.00 and a completion date of November 30, 2021. Biofire Diagnostics LLC is a leader in syndromic infectious disease testing and has...